Posts By Alex
-
8.5KWire StoriesHighField Biopharmaceuticals’ mRNA-based HFG1 Demonstrates Potential as a Longer Acting GLP-1R Agonist for Diabetic Control and Weight Loss
Preclinical results in naturally occurred diabetic monkeys were presented at the American Diabetes Association 84th Scientific Sessions, June 21-24, 2024 HighField plans...
-
14.5KWire StoriesTrustQuay Viewpoint Rebrands to Quantios Following Successful Merger
LONDON–(BUSINESS WIRE)–TrustQuay Viewpoint, a global SaaS provider to the Wealth, Trust and Corporate services (TCSP) industry has rebranded to Quantios, as the...
-
12.9KWire StoriesTakeda Announces Approval of LIVTENCITY® (maribavir) in Japan for Post-Transplant Cytomegalovirus (CMV) Infection/Disease That Is Refractory to Existing Anti-CMV Therapies
LIVTENCITY Is the First and Only Post-Transplant Anti-CMV Treatment Approved in Japan That Targets/Inhibits UL97 Protein Kinase1 CMV Is One of the...
-
12.5KWire StoriesMegaport and Lufthansa Systems Announce Landmark Partnership to Accelerate Airline Digital Transformation
With this strategic partnership, Lufthansa Systems will use Megaport’s Software Defined Network to digitally transform the aviation industry. BRISBANE, Australia–(BUSINESS WIRE)–Megaport Limited...
-
15.1KWire StoriesBayer and Solynta Collaborate to Advance True Potato Seed in Smallholder Markets
WAGENINGEN, Netherlands–(BUSINESS WIRE)–Bayer and Solynta have reached an agreement to collaborate on the commercialization and distribution of true potato seeds in Kenyan...
-
10.2KWire StoriesAdaptive Shield Announces Major ANZ Expansion to Bolster SaaS Security for Organizations
Grows presence in the region amid increasing cybersecurity threats on SaaS applications TEL AVIV, Israel & SYDNEY–(BUSINESS WIRE)–#AISA—Adaptive Shield, the leader in...
-
14.3KWire StoriesTakeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia
Mezagitamab-Treated Patients Showed Rapid and Sustained Increases in Platelet Counts That Persisted 8 Weeks After the Last Dose Through to Week 161...
-
14.9KWire StoriesAviation Luxury Lands at Dodger Stadium for STARLUX Airlines’ “STARLUX Night” Debut
The Dodgers’ Exclusive Taiwanese Airline Partner event celebrated with baseball legend Hong-Chih Kuo, activation booth, signature cocktails, drone show, roundtrip tickets, hotel...
-
9.9KWire StoriesPMC Biogenix Announces Expansion and Restructure
MEMPHIS, Tenn.–(BUSINESS WIRE)–PMC Biogenix, the leading sustainable producer of specialty fatty amides and high-value biobased products, announces the construction and expansion of...
-
13.9KWire StoriesTakeda Receives Approval from European Commission for FRUZAQLA in Previously Treated Metastatic Colorectal Cancer
− Approval Based on Results from Positive, Global, Phase 3 FRESCO-2 Trial − FRUZAQLA (fruquintinib) is the First Novel Targeted Therapy in...
To Top